BREAKING NEWS
“Chinnara Banna-2024” held successfully in Bantwal
Kadaba: Scooter rider’s death in tree fall – Public protests, demands removal of hazardous trees
Bantwal: Old video of elderly woman bursting firecrackers in hand goes viral
3rd Test: India strike early after taking slender lead against New Zealand at tea on day 2
BJP to hold statewide protest against alleged land seizure by Waqf board
Youth attacked during Karnataka Rajyotsava procession in Belagavi
20 KREIS schools in Kalaburagi, Belagavi get classes on good eating habits
My statement on ‘Shakti scheme’ was distorted, says Deputy CM Shivakumar
Karnataka Rajyotsava celebration draws massive crowds in Belagavi
Actor Darshan admitted to hosp for treatment following release on interim bail
BJP seeks Kharge, Rahul Gandhi’s apology over Cong chief’s remarks on poll promises
BJP MLA Yatnal urges PM Modi for nationalization of waqf properties
Changed loyalties, Baba Siddique murder to cast shadow on election in Bandra East
IPL 2025: Rishabh Pant released by DC, Klaasen pips Kohli in retention price
All those who work at Tirumala should be Hindus, says newly-appointed chairman of TTD
Glenmark Pharma gets final USFDA nod for generic version of Abiraterone Acetate tabs
PTI, May 20, 2022, 10:19 AM IST
New Delhi: Glenmark Pharmaceuticals Ltd on Friday said its US arm has received final approval from the US health regulator for its generic version of Abiraterone Acetate tablets used for the treatment of prostate cancer.
The approval granted by the US Food and Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc, USA (Glenmark) is for Abiraterone Acetate tablets of strength of 500 mg, the company said in a statement.
It is the generic version of Zytiga tablets, 500 mg, of Janssen Biotech Inc, it added.
Citing IQVIA sales data for the 12-month period ended March 2022, the company said Zytiga tablets 500 mg achieved annual sales of approximately USD 260.2 million.
Glenmark said its current portfolio consists of 173 products authorized for distribution in the US marketplace and 49 abbreviated new drug applications pending approval with the USFDA.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Attention problems could be ‘middleman’ between genetic risk for, experiencing psychosis: Study
Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study
Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study
Study finds loss of smell linked with inflammation in 140 conditions, could be early sign of disease
Manipal Centre for Biotherapeutics Research hosts “Cell Therapy Conclave” at Kasturba Medical College, Manipal
MUST WATCH
Latest Additions
CM Siddaramaiah promises efforts to include Kannada label on products made in Karnataka
“Chinnara Banna-2024” held successfully in Bantwal
Kharge getting personal on PM’s political observations on Karnataka surprising: BJP MP
India trashes Canada’s allegations against Amit Shah as ‘absurd and baseless’
K’taka CM Siddaramaiah orders withdrawal of notices to farmers over Waqf land disputes
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.